Innovations in HIV Treatment: Improving Patient Access, Adherence, and Treatment Satisfaction

Overview

Intended Audience: HIV prevention and treatment team members-including physicians, NPs/PAs, pharmacists, nurses, and case managers-in infectious disease and primary care settings

With more antiretroviral therapy (ART) options than ever before, providers must stay up-to-date with new and emerging treatments to support simple, safe, and effective HIV care while prioritizing patient satisfaction and preferences. Stay on the cutting edge of clinical practice and tune in to this webinar as HIV experts review the latest evidence, guidelines, and best practices for optimizing clinic workflows to support treatment access, medication adherence, and patient engagement.

This webinar is delivered in partnership with The AIDS Institute.

Learning Objectives

Differentiate new and emerging ART regimens based on efficacy, safety, adherence potential, drug-drug interactions, and patient-reported outcomes
Incorporate team-driven and technology-based practices to ensure uninterrupted HIV care and to maximize patient education and adherence support
Integrate shared decision-making and patient counseling in treatment selection to ensure optimal adherence and patient satisfaction

Agenda

Differentiating New and Emerging HIV Treatment Options, Including 2- and 3-Drug Regimens and Long-Acting Medications Based on Safety, Efficacy, Adherence Potential, and Patient-Reported Outcomes
Optimizing Clinic Workflows to Ensure Uninterrupted Treatment Access and Adherence Support
Integrating Shared Decision-Making in Treatment Selection to Optimize Adherence and Patient Satisfaction

Faculty

Ben J Barnett, MD, FACP, FIDSA

Speaker

Professor of Medicine, Infectious Diseases
Harris Health System
Houston, TX

W David Hardy, MD, AAHIVS

Speaker

Adjunct Professor of Medicine
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, MD

Milena Murray, PharmD, MSc, BCIDP, AAHIVP

Moderator

Associate Professor of Pharmacy Practice
Midwestern University College of Pharmacy, Downers Grove
Downers Grove, IL
ID/HIV Clinical Pharmacist
Northwestern Memorial Hospital
Chicago, IL

Joyce M Knestrick, PhD, CRNP, FAANP

Planner

Visiting Professor
George Washington University
Family Nurse Practitioner
Wheeling Health Right
Wheeling, WV

Ricardo Correa, MD, EdD, FACP, FACE, FAPCR, FACMQ

Planner

Fellowship Director, Endocrinology, Diabetes and Metabolism
Director of Diversity, Graduate Medical Education
University of Arizona College of Medicine
Phoenix, AZ

Abimbola Farinde, PhD, PharmD

Planner and Peer Reviewer

Professor of Health Care Administration
Columbia Southern University College of Business
Orange Beach, AL

CE Details & Instructions

Joint Accreditation Statement

In support of improving patient care, PRIME® is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Interprofessional Teams

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credits for learning and change.

Physician Credit Designation Statement

PRIME® designates this Live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Physician Assistant Accreditation Statement

PRIME® has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.

Nurse Practitioner Accreditation Statement

Nurse Practitioner Logo PRIME Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 060815. This activity is approved for 1.0 contact hour (which includes 0 hour of pharmacology).

Pharmacist Accreditation Statement

This Application-based activity has been approved for 1.0 contact hour (0.1 CEUs) by PRIME® for pharmacists. The Universal Activity Number for this activity is JA0007144-0000-21-054-L02-P . Pharmacy CE credits can be submitted to the NABP upon successful completion of the activity by providing your NABP ID & DOB, which must be submitted within 60 days of completion. Pharmacists with questions can contact NABP customer service ([email protected]).

Nurse Accreditation Statement

PRIME® designates this activity for 1.0 contact hour.

Case Manager Accreditation Statement

The Commission for Case Manager Certification designates this educational activity for 1.0 contact hour for certified case managers. Credits for this program are pre-approved.

Obtaining CE Credit

Register using the online form
Complete the pre-registration survey
Attend the live program in its entirety
Complete an online evaluation and post-test
Download and/or print a certificate of completion and/or submit CE credits electronically

Instructions to access CME/CE credit options will be provided at the end of the program.

Method of Participation

This live CME/CE activity requires attendance of the participant during the entire program and completion of learner assessment tools. The learner will then receive instructions on how to download and/or print a certificate of completion and/or submit CE credits electronically.

Device Requirements

Hardware: an Internet-enabled computer, smartphone, tablet, or mobile device with audio capabilities and Internet connectivity
Software: the installation of software such as GoToWebinar may be required

Faculty Disclosures

*PRIME® has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity.

The following individuals have identified relevant financial relationships with commercial interests to disclose:

Ben J Barnett, MD, FACP, FIDSA (Speaker)

Advisory Board or Panel – Janssen Therapeutics, ViiV Healthcare
Speakers Bureau or other Promotional Education – Gilead Sciences, Merck, Thera Technologies, ViiV Healthcare
W David Hardy, MD, AAHIVS (Speaker)

Advisory Board or Panel – Gilead Sciences, GlaxoSmithKline/ViiV Healthcare, Merck
Consultant – Enochian Biosciences, GlaxoSmithKline/ViiV Healthcare
Milena Murray, PharmD, MSc, BCIDP, AAHIVP (Moderator)

Advisory Board or Panel – Theratechnologies, Viiv
Speakers Bureau or other Promotional Education – Merck
Dora A Martinez, MD, FAAFP, AAHIVS (Speaker)

Speakers Bureau or other Promotional Education – Gilead Sciences, Janssen Pharmaceutical, ViiV Healthcare
David Koren, PharmD, MPH, BCPS, AAHIVP (Moderator)

Advisory Board or Panel – Gilead Sciences, Thera, ViiV Healthcare
Consultant – AbbVie, Gilead Sciences, Thera
Arianna Inurritegui-Lint (Contributing Author)

Advisory Board or Panel – HRC, NMAC, ViiV Healthcare
Paul E Sax, MD (Speaker)

Advisory Board or Panel – AbbVie, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline/ViiV Healthcare, Janssen, Merck
Consultant – AbbVie, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline/ViiV Healthcare, Janssen, Merck
Grants / Research Support – Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline/ViiV Healthcare, Merck
Adam M Spivak, MD (Speaker)

Advisory Board or Panel – Gilead Sciences, Horizon Therapeutics
Jonathan S Appelbaum, MD, FACP, AAHIVS (Speaker)

Advisory Board or Panel – Merck, Viiv Healthcare
Chad J Zawitz, MD (Speaker)

Speakers Bureau or other Promotional Education – Gilead Sciences
Errol L Fields, MD, PhD, MPH (Speaker)

Advisory Board or Panel – Gilead Sciences
William R Short, MD, MPH, AAHIVS (Speaker)

Advisory Board or Panel – Gilead Sciences, Janssen, ViiV Healthcare
Speakers Bureau or other Promotional Education – Janssen
Eric S Daar, MD (Speaker)

Consultant – Genentech, Gilead Sciences, Merck
Grants / Research Support – Gilead Sciences, Merck, ViiV Healthcare
Joseph J Eron, Jr, MD (Speaker)

Consultant – Gilead Sciences, Janssen, Merck, ViiV Healthcare
Grants / Research Support – Gilead Sciences, To University of North Carolina: Bristol Myers Squibb, To University of North Carolina: Gilead Sciences, To University of North Carolina: ViiV Healthcare

The following individuals have no relevant financial relationships with commercial interests to disclose:

Joanne D Stekler, MD, MPH (Speaker)
Ryan W Nall, MD (Speaker)
Melissa E Badowski, PharmD, MPH, FCCP, BCIDP, BCPS, AAHIVP (Moderator)
Waridibo Allison, MD, PhD, FACP (Speaker)
Gerald Garth (Author)
Lynnea Lawson (Author)
Raul Quintero (Author)
Michelle D Collins-Ogle, MD, FPIDS, FAAP, AAHIVS (Speaker)
Asa E Radix, MD, PhD, MPH, FACP (Speaker)
Marc O Siegel, MD (Speaker)
Evany Turk (Author)
Masonia Traylor (Author)
Mary W Montgomery, MD (Speaker)
Abimbola Farinde, PhD, PharmD (Planner, Reviewer)
Joyce M Knestrick, PhD, CRNP, FAANP (Planner)
Ricardo Correa, MD, EdD, FACP, FACE, FAPCR, FACMQ (Planner)

All PRIME® staff participating in planning and content development have no relevant financial relationships with commercial interests to disclose.

Funding Disclosure

This activity is provided by PRIME Education. There is no fee to participate. This activity is supported by educational grants from Gilead Sciences, Inc., Janssen Therapeutics, Division of Janssen Products, LP, Merck & Co. Inc. and ViiV Healthcare.

Accessibility Statement

At PRIME, we are committed to ensuring that individuals with disabilities can access all of the content offered by PRIME through our website and other properties. If you are having trouble accessing primeinc.org, please email [email protected] for assistance. Please put "ADA Inquiry" in the subject line of your email.

Summary


Cost:	FREE


Credit:	No Credit Offered

Create Account